Nissay Asset Management Corp Japan ADV Acquires 4,837 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nissay Asset Management Corp Japan ADV increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 81,790 shares of the medical equipment provider's stock after buying an additional 4,837 shares during the period. Nissay Asset Management Corp Japan ADV's holdings in Intuitive Surgical were worth $43,748,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Atala Financial Inc bought a new stake in Intuitive Surgical in the 4th quarter valued at about $25,000. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Finally, Hurley Capital LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 810 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at $271,397.94. This represents a 63.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $566.94, for a total transaction of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares of the company's stock, valued at approximately $4,060,424.28. This represents a 2.56% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 32,700 shares of company stock worth $16,865,621. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.6%

NASDAQ ISRG traded up $3.32 on Friday, hitting $563.60. The company's stock had a trading volume of 1,422,176 shares, compared to its average volume of 1,644,552. Intuitive Surgical, Inc. has a 1-year low of $395.60 and a 1-year high of $616.00. The company's 50-day moving average is $505.22 and its 200 day moving average is $536.61. The firm has a market cap of $202.00 billion, a PE ratio of 87.93, a PEG ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the firm posted $1.50 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Robert W. Baird cut their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Leerink Partners boosted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Erste Group Bank cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Finally, BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $598.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.